N-Acetyl Semax vs Noopept
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
N-Acetyl Semax
N-Acetyl Semax is the acetylated form of Semax — an N-terminal acetyl group added to the standard Semax heptapeptide. The modification significantly improves resistance to aminopeptidases, extending the active half-life and producing a more sustained cognitive effect at lower doses. Considered by many researchers to be the preferred form of Semax for neurotrophin upregulation and focus enhancement.
Full profileNoopept
Dipeptide-derived nootropic developed in Russia and used across Eastern Europe as a cognitive enhancer and neuroprotective agent. Structurally related to piracetam but estimated to be approximately 1000× more potent by weight. Rapidly crosses the blood-brain barrier and is hydrolyzed to the endogenous neuropeptide cycloprolylglycine, which is proposed as its primary active metabolite.
Full profile| N-Acetyl Semax | Noopept | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | NA-Semax, Acetyl-Semax, N-Ac-MEHFPGP | GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester, omberacetam, N-Phenylacetyl-L-Prolylglycine Ethyl Ester |
| Evidence | Research-stage | Research-stage |
| Dosing range | 100mcg–600mcg mcg, Once daily (intranasal preferred) | 5mg–20mg mg, 1–3x daily oral or sublingual (8–12 week cycles) |
| Administration | Intranasal (preferred), Subcutaneous injection | Oral (capsule/powder), Sublingual (dissolved under tongue), Intranasal |
| Key side effects | Mild anxiety or over-stimulation at high doses, Nasal irritation (intranasal), Difficulty sleeping if dosed late in the day (more stimulating than standard Semax), Mild appetite suppression | Headache (especially without choline supplementation), Irritability, Brain fog at high doses, Insomnia (if taken too late in day) |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: N-Acetyl Semax — Intranasal (preferred), Subcutaneous injection; Noopept — Oral (capsule/powder), Sublingual (dissolved under tongue), Intranasal.
- Dosing units differ: N-Acetyl Semax is dosed in mcg, Noopept in mg — they operate at different scales.
- Frequency: N-Acetyl Semax is typically Once daily (intranasal preferred); Noopept is 1–3x daily oral or sublingual (8–12 week cycles).
How each works
N-Acetyl Semax
Acetylation of the N-terminus blocks aminopeptidase cleavage at the most vulnerable site on the Semax molecule, extending its effective duration in biological fluids. Studies comparing acetylated vs non-acetylated ACTH fragment analogs consistently show greater stability and sustained receptor engagement with acetylated forms. N-Acetyl Semax demonstrates the same core BDNF/NGF upregulating and neuroprotective profile as Semax with reported greater potency per mcg due to improved bioavailability.
Noopept
Noopept (GVS-111) enhances AMPA-receptor function and increases expression of BDNF and NGF in the hippocampus and basal forebrain. Its active metabolite cycloprolylglycine acts as an endogenous neuropeptide with anxiolytic and cognition-enhancing properties. Russian clinical trials demonstrate cognitive improvement in subjects with cognitive impairment, with a better tolerability profile than piracetam at equipotent doses.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.